XURIDEN Drug Patent Profile
✉ Email this page to a colleague
When do Xuriden patents expire, and what generic alternatives are available?
Xuriden is a drug marketed by Btg Intl and is included in one NDA.
The generic ingredient in XURIDEN is uridine triacetate. There are thirty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the uridine triacetate profile page.
Summary for XURIDEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Patent Applications: | 287 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for XURIDEN |
What excipients (inactive ingredients) are in XURIDEN? | XURIDEN excipients list |
DailyMed Link: | XURIDEN at DailyMed |
Pharmacology for XURIDEN
Ingredient-type | Analogs/Derivatives Pyrimidines |
Drug Class | Pyrimidine Analog |
Anatomical Therapeutic Chemical (ATC) Classes for XURIDEN
US Patents and Regulatory Information for XURIDEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Btg Intl | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XURIDEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Btg Intl | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XURIDEN
See the table below for patents covering XURIDEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2003201240 | METHOD FOR REDUCING TOXICITY OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT WITH ACYLATED PYRIMIDINE NUCLEOSIDE | ⤷ Sign Up |
European Patent Office | 0594667 | TRAITEMENT D'UN AGENT CHIMIOTHERAPEUTIQUE ET DE LA TOXICITE D'UN AGENT ANTIVIRAL PAR DES NUCLEOSIDES DE PYRIMIDINE ACYLEE (TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES) | ⤷ Sign Up |
Denmark | 174400 | ⤷ Sign Up | |
European Patent Office | 1491201 | Procédés de réduction de la toxicité de 5-fluorouracil avec des nucléosides pyrimidiniques acylés (Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for XURIDEN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1849470 | 2017C/028 | Belgium | ⤷ Sign Up | PRODUCT NAME: LONSURF - TRIFLURIDINE/TIPIRACIL; AUTHORISATION NUMBER AND DATE: EU/1/16/1096 20160427 |
1849470 | CA 2017 00036 | Denmark | ⤷ Sign Up | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF TIPIRACIL; REG. NO/DATE: EU/1/16/1096 20160427 |
2207786 | LUC00327 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: CEDAZURIDINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; AUTHORISATION NUMBER AND DATE: EU/1/23/1756 20230918 |
1849470 | 17C1028 | France | ⤷ Sign Up | PRODUCT NAME: TRIFLURIDINE/TIPIRACIL; REGISTRATION NO/DATE: EU/1/16/1096 20160427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |